Results 201 to 210 of about 357,387 (353)

CDH1 Orchestrates Anabolic Events to Promote Cell Cycle Initiation

Advanced Science, EarlyView.
Cell proliferation requires the integration of cell cycle and anabolic signals. G1‐phase regulator CDH1 coordinates anabolism through the CDH1‐VHL‐AARS2/HIF1α axis, while CDH1‐accumulated R5P is sensed by TKTL1 to facilitate CDH1 degradation and cell cycle initiation, constituting a CDH1‐centered regulatory circuit.
Yun‐Zi Mao, Jiao‐Jiao Zhang, Meng‐Qi You, Han Wang, Yan Lin, Yuan Fang, Hui‐Lu Zhang, Yuan‐Yuan Qu, Qian Zhou, Meng Wang, Gang Li, Zi‐Fan Guo, Meng Xu, Jie Liu, Peng‐Cheng Lin, Yi‐Yuan Yuan, Yu Kang, Shi‐Min Zhao, Wei Xu   +18 more
wiley   +1 more source

Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors? [PDF]

Biomedicines
Failla CM, Carbone ML, Ramondino C, Bruni E, Orecchia A.   +4 more
europepmc   +1 more source

Retracted: Correlation of CT Perfusion Parameters and Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (BFGF) in Patients with Primary Liver Cancer. [PDF]

Evid Based Complement Alternat Med, 2023
And Alternative Medicine EC.
europepmc   +1 more source

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors* [PDF]

, 2001
Gerold Holzer, Andreas Obermair, Martin A. Koschat, Oliver Preyer, R. Kotz, Klemens Trieb   +5 more
openalex   +1 more source

Multiscale Construction, Evaluation, and Application of Organoids

Advanced Science, EarlyView.
Organoids are pivotal models with transformative biomedical potential. A comprehensive multi‐scale perspective is presented, encompassing dual‐scale construction, four‐dimensional evaluation, triple‐point application, and an analysis of the current challenges faced by organoid technology, aiming to advance organoid research and its biomedical ...
Wanting Ma, Zhenglin Dong, Zhu'anzhen Zheng, Long Bai, Xingcai Zhang, Jiacan Su   +5 more
wiley   +1 more source

Early Pars Plana Vitrectomy and Anti-vascular Endothelial Growth Factor (VEGF) in the Management of Terson Syndrome: A Case Linked to Methicillin-Resistant Staphylococcus aureus (MRSA) Meningitis. [PDF]

Cureus
Ağın A, Karaca D, Kilic S, Onder F.
europepmc   +1 more source

Does the Expression of Vascular Endothelial Growth Factor (VEGF) and Bcl-2 Have a Prognostic Significance in Advanced Non-Small Cell Lung Cancer? [PDF]

Healthcare (Basel), 2023
Markovic M, Mitrovic S, Dagovic A, Jovanovic D, Nikolic T, Ivosevic A, Milosavljevic MZ, Vojinovic R, Petrovic M.   +8 more
europepmc   +1 more source

In Situ Engineering of Tumor Cells as Self‐Sustaining cDC1 Programming Factories for Effective Cancer Immunotherapy

Advanced Science, EarlyView.
The fused EV platform AS16‐EL@MPLA/p‐FX reprograms tumor cells into cytokine‐producing factories that continuously secrete XCL1 and FLT3L to recruit and differentiate cDC1s, while embedded MPLA activates them through TLR4 signaling and AS16 prevents their exhaustion, thereby enhancing antitumor immunity and establishing durable immune memory against ...
Shuiling Jin, Xiaoxi Wang, Bingyu Li, Xueqin Zhu, Zimai Liu, Jiao Lu, Yuanyuan Wei, Zixian Wu, Kai Li, Tiantian Zhang, Zonghong He, Pingping Zhu, Yuanming Qi, Benyu Liu, Hui Liu, Yongchao Wang, Zhenzhen Chen   +16 more
wiley   +1 more source

Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Cancer-Associated Venous Thrombosis: A Meta-analysis. [PDF]

TH Open
Brown AM, Nock S, Musgrave K, Unsworth AJ.   +3 more
europepmc   +1 more source

Modeling the Cluster Size Distribution of Vascular Endothelial Growth Factor (VEGF) Receptors. [PDF]

Bioinform Biol Insights, 2022
Güven E, Wester MJ, Edwards JS, Halász ÁM.   +3 more
europepmc   +1 more source